Cyclic 3',5'-nucleotide phosphodiesterase. Evidence for and properties of a protein activator

Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial.

Nature medicine·2024

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Immunotherapy advances·2022

Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021

Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil.

Current oncology (Toronto, Ont.)·2020

A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes.

Current oncology (Toronto, Ont.)·2020

Subtype-specific risk factors for postmenopausal breast cancer: findings from the PLCO trial.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020